ARCHIVES

Fondaparinux Prevents DVT In Acutely III Medical Patients

This article is from The Cancer Letter archive.

Vol. 27 No. 1 | January 30, 2004

Download PDF Visit The Full Archive

Related Articles

In Radio Address, Clinton Outlines Administration Priorities

October 2, 1998

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

Bevacizumab And Irinotecan May Increase Survival Of GBM

October 26, 2007

NCI Disappointed Over Response To Survey Leads; CRAG Proposals Inadequate, More Will Be Sought

August 6, 1976

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

March 5, 1999

DCT Board to Study Modifications Of Existing Cooperative Group System

June 13, 1986